Association between antenatal corticosteroids and risk of serious infection in children: nationwide cohort study
AbstractObjectiveTo investigate the associations between exposure to antenatal corticosteroids and serious infection in children during the first three, six, and 12 months of life.DesignNationwide cohort study.SettingNational Health Insurance Research Database, Birth Reporting Database, and Maternal...
Saved in:
Published in | BMJ (Online) Vol. 382; p. e075835 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
British Medical Journal Publishing Group
02.08.2023
BMJ Publishing Group LTD |
Subjects | |
Online Access | Get full text |
ISSN | 1756-1833 1756-1833 |
DOI | 10.1136/bmj-2023-075835 |
Cover
Abstract | AbstractObjectiveTo investigate the associations between exposure to antenatal corticosteroids and serious infection in children during the first three, six, and 12 months of life.DesignNationwide cohort study.SettingNational Health Insurance Research Database, Birth Reporting Database, and Maternal and Child Health Database, 1 January 2008 to 31 December 2019, to identify all pregnant individuals and their offspring in Taiwan.Participants1 960 545 pairs of pregnant individuals and their singleton offspring. 45 232 children were exposed and 1 915 313 were not exposed to antenatal corticosteroids.Main outcome measuresIncidence rates were estimated for overall serious infection, sepsis, pneumonia, acute gastroenteritis, pyelonephritis, meningitis or encephalitis, cellulitis or soft tissue infection, septic arthritis or osteomyelitis, and endocarditis during the first three, six, and 12 months of life in children exposed versus those not exposed to antenatal corticosteroids. Cox proportional hazards models were performed to quantify adjusted hazard ratios with 95% confidence intervals for each study outcome.ResultsThe study cohort was 1 960 545 singleton children: 45 232 children were exposed to one course of antenatal corticosteroids and 1 915 313 children were not exposed to antenatal corticosteroids. The adjusted hazard ratios for overall serious infection, sepsis, pneumonia, and acute gastroenteritis among children exposed to antenatal corticosteroids were significantly higher than those not exposed to antenatal corticosteroids during the first six months of life (adjusted hazard ratio 1.32, 95% confidence interval 1.18 to 1.47, P<0.001, for overall serious infection; 1.74, 1.16 to 2.61, P=0.01, for sepsis; 1.39, 1.17 to 1.65, P<0.001, for pneumonia; and 1.35, 1.10 to 1.65, P<0.001, for acute gastroenteritis).Similarly, the adjusted hazard ratios for overall serious infection (P<0.001), sepsis (P=0.02), pneumonia (P<0.001), and acute gastroenteritis (P<0.001) were significantly higher from birth to 12 months of life. In the sibling matched cohort, the results were comparable with those observed in the whole cohort, with a significantly increased risk of sepsis in the first six (P=0.01) and 12 (P=0.04) months of life.ConclusionsThis nationwide cohort study found that children exposed to one course of antenatal corticosteroids were significantly more likely to have an increased risk of serious infection during the first 12 months of life. These findings suggest that before starting treatment, the long term risks of rare but serious infection associated with antenatal corticosteroids should be carefully weighed against the benefits in the perinatal period. |
---|---|
AbstractList | To investigate the associations between exposure to antenatal corticosteroids and serious infection in children during the first three, six, and 12 months of life.
Nationwide cohort study.
National Health Insurance Research Database, Birth Reporting Database, and Maternal and Child Health Database, 1 January 2008 to 31 December 2019, to identify all pregnant individuals and their offspring in Taiwan.
1 960 545 pairs of pregnant individuals and their singleton offspring. 45 232 children were exposed and 1 915 313 were not exposed to antenatal corticosteroids.
Incidence rates were estimated for overall serious infection, sepsis, pneumonia, acute gastroenteritis, pyelonephritis, meningitis or encephalitis, cellulitis or soft tissue infection, septic arthritis or osteomyelitis, and endocarditis during the first three, six, and 12 months of life in children exposed versus those not exposed to antenatal corticosteroids. Cox proportional hazards models were performed to quantify adjusted hazard ratios with 95% confidence intervals for each study outcome.
The study cohort was 1 960 545 singleton children: 45 232 children were exposed to one course of antenatal corticosteroids and 1 915 313 children were not exposed to antenatal corticosteroids. The adjusted hazard ratios for overall serious infection, sepsis, pneumonia, and acute gastroenteritis among children exposed to antenatal corticosteroids were significantly higher than those not exposed to antenatal corticosteroids during the first six months of life (adjusted hazard ratio 1.32, 95% confidence interval 1.18 to 1.47, P<0.001, for overall serious infection; 1.74, 1.16 to 2.61, P=0.01, for sepsis; 1.39, 1.17 to 1.65, P<0.001, for pneumonia; and 1.35, 1.10 to 1.65, P<0.001, for acute gastroenteritis).Similarly, the adjusted hazard ratios for overall serious infection (P<0.001), sepsis (P=0.02), pneumonia (P<0.001), and acute gastroenteritis (P<0.001) were significantly higher from birth to 12 months of life. In the sibling matched cohort, the results were comparable with those observed in the whole cohort, with a significantly increased risk of sepsis in the first six (P=0.01) and 12 (P=0.04) months of life.
This nationwide cohort study found that children exposed to one course of antenatal corticosteroids were significantly more likely to have an increased risk of serious infection during the first 12 months of life. These findings suggest that before starting treatment, the long term risks of rare but serious infection associated with antenatal corticosteroids should be carefully weighed against the benefits in the perinatal period. AbstractObjectiveTo investigate the associations between exposure to antenatal corticosteroids and serious infection in children during the first three, six, and 12 months of life.DesignNationwide cohort study.SettingNational Health Insurance Research Database, Birth Reporting Database, and Maternal and Child Health Database, 1 January 2008 to 31 December 2019, to identify all pregnant individuals and their offspring in Taiwan.Participants1 960 545 pairs of pregnant individuals and their singleton offspring. 45 232 children were exposed and 1 915 313 were not exposed to antenatal corticosteroids.Main outcome measuresIncidence rates were estimated for overall serious infection, sepsis, pneumonia, acute gastroenteritis, pyelonephritis, meningitis or encephalitis, cellulitis or soft tissue infection, septic arthritis or osteomyelitis, and endocarditis during the first three, six, and 12 months of life in children exposed versus those not exposed to antenatal corticosteroids. Cox proportional hazards models were performed to quantify adjusted hazard ratios with 95% confidence intervals for each study outcome.ResultsThe study cohort was 1 960 545 singleton children: 45 232 children were exposed to one course of antenatal corticosteroids and 1 915 313 children were not exposed to antenatal corticosteroids. The adjusted hazard ratios for overall serious infection, sepsis, pneumonia, and acute gastroenteritis among children exposed to antenatal corticosteroids were significantly higher than those not exposed to antenatal corticosteroids during the first six months of life (adjusted hazard ratio 1.32, 95% confidence interval 1.18 to 1.47, P<0.001, for overall serious infection; 1.74, 1.16 to 2.61, P=0.01, for sepsis; 1.39, 1.17 to 1.65, P<0.001, for pneumonia; and 1.35, 1.10 to 1.65, P<0.001, for acute gastroenteritis).Similarly, the adjusted hazard ratios for overall serious infection (P<0.001), sepsis (P=0.02), pneumonia (P<0.001), and acute gastroenteritis (P<0.001) were significantly higher from birth to 12 months of life. In the sibling matched cohort, the results were comparable with those observed in the whole cohort, with a significantly increased risk of sepsis in the first six (P=0.01) and 12 (P=0.04) months of life.ConclusionsThis nationwide cohort study found that children exposed to one course of antenatal corticosteroids were significantly more likely to have an increased risk of serious infection during the first 12 months of life. These findings suggest that before starting treatment, the long term risks of rare but serious infection associated with antenatal corticosteroids should be carefully weighed against the benefits in the perinatal period. ObjectiveTo investigate the associations between exposure to antenatal corticosteroids and serious infection in children during the first three, six, and 12 months of life.DesignNationwide cohort study.SettingNational Health Insurance Research Database, Birth Reporting Database, and Maternal and Child Health Database, 1 January 2008 to 31 December 2019, to identify all pregnant individuals and their offspring in Taiwan.Participants1 960 545 pairs of pregnant individuals and their singleton offspring. 45 232 children were exposed and 1 915 313 were not exposed to antenatal corticosteroids.Main outcome measuresIncidence rates were estimated for overall serious infection, sepsis, pneumonia, acute gastroenteritis, pyelonephritis, meningitis or encephalitis, cellulitis or soft tissue infection, septic arthritis or osteomyelitis, and endocarditis during the first three, six, and 12 months of life in children exposed versus those not exposed to antenatal corticosteroids. Cox proportional hazards models were performed to quantify adjusted hazard ratios with 95% confidence intervals for each study outcome.ResultsThe study cohort was 1 960 545 singleton children: 45 232 children were exposed to one course of antenatal corticosteroids and 1 915 313 children were not exposed to antenatal corticosteroids. The adjusted hazard ratios for overall serious infection, sepsis, pneumonia, and acute gastroenteritis among children exposed to antenatal corticosteroids were significantly higher than those not exposed to antenatal corticosteroids during the first six months of life (adjusted hazard ratio 1.32, 95% confidence interval 1.18 to 1.47, P<0.001, for overall serious infection; 1.74, 1.16 to 2.61, P=0.01, for sepsis; 1.39, 1.17 to 1.65, P<0.001, for pneumonia; and 1.35, 1.10 to 1.65, P<0.001, for acute gastroenteritis).Similarly, the adjusted hazard ratios for overall serious infection (P<0.001), sepsis (P=0.02), pneumonia (P<0.001), and acute gastroenteritis (P<0.001) were significantly higher from birth to 12 months of life. In the sibling matched cohort, the results were comparable with those observed in the whole cohort, with a significantly increased risk of sepsis in the first six (P=0.01) and 12 (P=0.04) months of life.ConclusionsThis nationwide cohort study found that children exposed to one course of antenatal corticosteroids were significantly more likely to have an increased risk of serious infection during the first 12 months of life. These findings suggest that before starting treatment, the long term risks of rare but serious infection associated with antenatal corticosteroids should be carefully weighed against the benefits in the perinatal period. To investigate the associations between exposure to antenatal corticosteroids and serious infection in children during the first three, six, and 12 months of life.OBJECTIVETo investigate the associations between exposure to antenatal corticosteroids and serious infection in children during the first three, six, and 12 months of life.Nationwide cohort study.DESIGNNationwide cohort study.National Health Insurance Research Database, Birth Reporting Database, and Maternal and Child Health Database, 1 January 2008 to 31 December 2019, to identify all pregnant individuals and their offspring in Taiwan.SETTINGNational Health Insurance Research Database, Birth Reporting Database, and Maternal and Child Health Database, 1 January 2008 to 31 December 2019, to identify all pregnant individuals and their offspring in Taiwan.1 960 545 pairs of pregnant individuals and their singleton offspring. 45 232 children were exposed and 1 915 313 were not exposed to antenatal corticosteroids.PARTICIPANTS1 960 545 pairs of pregnant individuals and their singleton offspring. 45 232 children were exposed and 1 915 313 were not exposed to antenatal corticosteroids.Incidence rates were estimated for overall serious infection, sepsis, pneumonia, acute gastroenteritis, pyelonephritis, meningitis or encephalitis, cellulitis or soft tissue infection, septic arthritis or osteomyelitis, and endocarditis during the first three, six, and 12 months of life in children exposed versus those not exposed to antenatal corticosteroids. Cox proportional hazards models were performed to quantify adjusted hazard ratios with 95% confidence intervals for each study outcome.MAIN OUTCOME MEASURESIncidence rates were estimated for overall serious infection, sepsis, pneumonia, acute gastroenteritis, pyelonephritis, meningitis or encephalitis, cellulitis or soft tissue infection, septic arthritis or osteomyelitis, and endocarditis during the first three, six, and 12 months of life in children exposed versus those not exposed to antenatal corticosteroids. Cox proportional hazards models were performed to quantify adjusted hazard ratios with 95% confidence intervals for each study outcome.The study cohort was 1 960 545 singleton children: 45 232 children were exposed to one course of antenatal corticosteroids and 1 915 313 children were not exposed to antenatal corticosteroids. The adjusted hazard ratios for overall serious infection, sepsis, pneumonia, and acute gastroenteritis among children exposed to antenatal corticosteroids were significantly higher than those not exposed to antenatal corticosteroids during the first six months of life (adjusted hazard ratio 1.32, 95% confidence interval 1.18 to 1.47, P<0.001, for overall serious infection; 1.74, 1.16 to 2.61, P=0.01, for sepsis; 1.39, 1.17 to 1.65, P<0.001, for pneumonia; and 1.35, 1.10 to 1.65, P<0.001, for acute gastroenteritis).Similarly, the adjusted hazard ratios for overall serious infection (P<0.001), sepsis (P=0.02), pneumonia (P<0.001), and acute gastroenteritis (P<0.001) were significantly higher from birth to 12 months of life. In the sibling matched cohort, the results were comparable with those observed in the whole cohort, with a significantly increased risk of sepsis in the first six (P=0.01) and 12 (P=0.04) months of life.RESULTSThe study cohort was 1 960 545 singleton children: 45 232 children were exposed to one course of antenatal corticosteroids and 1 915 313 children were not exposed to antenatal corticosteroids. The adjusted hazard ratios for overall serious infection, sepsis, pneumonia, and acute gastroenteritis among children exposed to antenatal corticosteroids were significantly higher than those not exposed to antenatal corticosteroids during the first six months of life (adjusted hazard ratio 1.32, 95% confidence interval 1.18 to 1.47, P<0.001, for overall serious infection; 1.74, 1.16 to 2.61, P=0.01, for sepsis; 1.39, 1.17 to 1.65, P<0.001, for pneumonia; and 1.35, 1.10 to 1.65, P<0.001, for acute gastroenteritis).Similarly, the adjusted hazard ratios for overall serious infection (P<0.001), sepsis (P=0.02), pneumonia (P<0.001), and acute gastroenteritis (P<0.001) were significantly higher from birth to 12 months of life. In the sibling matched cohort, the results were comparable with those observed in the whole cohort, with a significantly increased risk of sepsis in the first six (P=0.01) and 12 (P=0.04) months of life.This nationwide cohort study found that children exposed to one course of antenatal corticosteroids were significantly more likely to have an increased risk of serious infection during the first 12 months of life. These findings suggest that before starting treatment, the long term risks of rare but serious infection associated with antenatal corticosteroids should be carefully weighed against the benefits in the perinatal period.CONCLUSIONSThis nationwide cohort study found that children exposed to one course of antenatal corticosteroids were significantly more likely to have an increased risk of serious infection during the first 12 months of life. These findings suggest that before starting treatment, the long term risks of rare but serious infection associated with antenatal corticosteroids should be carefully weighed against the benefits in the perinatal period. |
Author | Wu, Chi-Shin Tsai, Hui-Ju Yao, Tsung-Chieh Sheen, Kun-Hua Hong, Xiumei Wu, Ann Chen Chang, Sheng-Mao Tsai, Yi-Fen Chen, Hui-Yu |
Author_xml | – sequence: 1 givenname: Tsung-Chieh orcidid: 0000-0002-5457-1402 surname: Yao fullname: Yao, Tsung-Chieh email: yao@adm.cgmh.org.tw organization: School of Medicine, Chang Gung University College of Medicine, Taoyuan, Taiwan – sequence: 2 givenname: Sheng-Mao surname: Chang fullname: Chang, Sheng-Mao organization: Department of Statistics, National Taipei University, Taipei, Taiwan – sequence: 3 givenname: Chi-Shin surname: Wu fullname: Wu, Chi-Shin organization: Department of Psychiatry, National Taiwan University Hospital, Yunlin Branch, Douliu, Taiwan – sequence: 4 givenname: Yi-Fen surname: Tsai fullname: Tsai, Yi-Fen organization: Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan – sequence: 5 givenname: Kun-Hua surname: Sheen fullname: Sheen, Kun-Hua organization: Department of Medical Science, National Tsing-Hua University, Hsinchu, Taiwan – sequence: 6 givenname: Xiumei surname: Hong fullname: Hong, Xiumei organization: Department of Population, Family, and Reproductive Health, Center on Early Life Origins of Disease, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA – sequence: 7 givenname: Hui-Yu surname: Chen fullname: Chen, Hui-Yu organization: Department of Pharmacy, Chang Gung Memorial Hospital, Taoyuan, Taiwan – sequence: 8 givenname: Ann Chen surname: Wu fullname: Wu, Ann Chen organization: Harvard Medical School, Boston, MA, USA – sequence: 9 givenname: Hui-Ju surname: Tsai fullname: Tsai, Hui-Ju organization: Department of Medical Science, National Tsing-Hua University, Hsinchu, Taiwan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37532264$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kc1LXDEUxUNRqp267k4Cbgrlab7nPXci_RAEN-065CU3mOmbZEzyEP97MzNaiuAqF-7vnBzu-YQOYoqA0BdKzinl6mJcrzpGGO_IUvZcfkDHdClVR3vOD_6bj9BJKStCGrnsByU_oiO-lJwxJY7R5qqUZIOpIUU8Qn0EiNjECtFUM2Gbcg02lQo5BVfaxuEcyl-cPC6QQ5oLDtGD3elDxPY-TC5DvMRx5_kYHDSX--aDS53d02d06M1U4OTlXaA_P77_vv7V3d79vLm-uu1GofraUUsHEJ554gWRzo3OyoERQSk4GKwVivkByCjaIZR00jrO-kEYYj0bR-r4An3d-25yepihVL0OxcI0mQgttWa9kEoqJlhDz96gqzTn2NJtKdFseftmgU5fqHlcg9ObHNYmP-nXWzZA7gGbUykZvLah7o5QswmTpkRva9OtNr2tTe9ra7qLN7pX6_cV3_aK7eJf1vfoZzE-qJk |
CitedBy_id | crossref_primary_10_1136_bmjmed_2024_000995 crossref_primary_10_1186_s12884_024_07013_w crossref_primary_10_3390_pathogens14010089 crossref_primary_10_7759_cureus_67977 crossref_primary_10_1038_s41372_023_01831_0 crossref_primary_10_1097_INF_0000000000004440 crossref_primary_10_1007_s40278_023_45390_5 crossref_primary_10_1111_1756_185X_15103 crossref_primary_10_1001_jamapediatrics_2024_4409 crossref_primary_10_1001_jamanetworkopen_2024_53284 crossref_primary_10_1038_s41390_024_03092_9 crossref_primary_10_1080_14656566_2025_2475190 crossref_primary_10_1159_000540078 crossref_primary_10_1038_s41390_024_03723_1 crossref_primary_10_1093_ibd_izad316 crossref_primary_10_1507_endocrj_EJ23_0725 crossref_primary_10_1002_uog_27619 crossref_primary_10_1080_14767058_2024_2434059 |
Cites_doi | 10.1001/jamapediatrics.2022.0483 10.1136/bmj.330.7497.960 10.1016/j.placenta.2007.04.002 10.1001/jama.1995.03520290065031 10.1203/00006450-200003000-00003 10.1016/j.mehy.2007.07.049 10.1371/journal.pone.0112257 10.1002/14651858.CD004454.pub4 10.1016/S1095-6433(01)00308-7 10.1001/jamadermatol.2019.1121 10.1046/j.1365-2265.1997.1230939.x 10.1001/jama.2020.3937 10.1002/aur.2835 10.1111/j.1742-7843.2006.pto_293.x 10.7326/M20-0432 10.1080/14767058.2020.1731455 10.1111/1471-0528.16677 10.1016/j.ajog.2022.10.002 10.1164/ajrccm.165.7.2105003 10.1159/000499361 10.1159/000502650 10.1001/jamapediatrics.2021.0433 10.1016/j.jpeds.2022.09.032 10.1002/sim.1903 10.1111/1471-0528.17027 10.1136/bmj.j1415 10.1016/S0095-5108(18)30093-9 10.1097/AOG.0000000000002237 10.1001/jamanetworkopen.2022.28518 |
ContentType | Journal Article |
Copyright | Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2023 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. – notice: 2023 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 9YT ACMMV AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88I 8AF 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AN0 ASE AZQEC BBNVY BENPR BHPHI BTHHO CCPQU DWQXO FPQ FYUFA GHDGH GNUQQ GUQSH HCIFZ K6X K9. KB0 LK8 M2O M2P M7P MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI Q9U 7X8 |
DOI | 10.1136/bmj-2023-075835 |
DatabaseName | BMJ Open Access Journals BMJ Journals:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Science Database (Alumni Edition) STEM Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland British Nursing Database (Proquest) British Nursing Index ProQuest Central Essentials Local Electronic Collection Information Biological Science Database ProQuest Central Natural Science Collection BMJ Journals ProQuest One ProQuest Central Korea British Nursing Index (BNI) (1985 to Present) Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library SciTech Premium Collection British Nursing Index ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences Research Library Science Database Biological Science Database Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest AP Science ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Research Library ProQuest Central (New) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition British Nursing Index with Full Text British Nursing Index ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition BMJ Journals ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Research Library Prep MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: ACMMV name: BMJ Journals:Open Access url: https://journals.bmj.com/ sourceTypes: Publisher – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1756-1833 |
ExternalDocumentID | 37532264 10_1136_bmj_2023_075835 bmj |
Genre | Journal Article |
GeographicLocations | Taiwan |
GeographicLocations_xml | – name: Taiwan |
GroupedDBID | 23N 39C 4.4 40O 53G 5GY 7RV 7X7 88I 8AF 8F7 8FE 8FH 8FI 8FJ 8G5 9YT AACGO AANCE AAWJN ABIVO ABJNI ABPLY ABTLG ABUWG ABVAJ ACGFS ACGOD ACMFJ ACMMV ACPRK AFKRA AGFXO AHMBA AHNKE AHQMW AJYBZ ALIPV ALMA_UNASSIGNED_HOLDINGS AZQEC BBNVY BENPR BHPHI BPHCQ BTHHO C45 CCPQU CS3 DWQXO EBS EJD F5P FYUFA GNUQQ GUQSH H13 HAJ HCIFZ HMCUK HZ~ JLS JSG L7B LK8 M2O M2P M7P NAPCQ NXWIF O9- OVD PHGZT PQQKQ PROAC R53 RHI RMJ RV8 TEORI UKHRP VVN WOQ YFH YQY AAYXX CITATION PHGZM CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB 3V. 7XB 8FK AN0 ASE FPQ K6X K9. MBDVC PKEHL PQEST PQUKI PUEGO Q9U 7X8 |
ID | FETCH-LOGICAL-b468t-1c19e4f2f0f405ddbdc5920411ede9cc462f9e0b413665d5cd32894a0cf2bb1d3 |
IEDL.DBID | 9YT |
ISSN | 1756-1833 |
IngestDate | Fri Sep 05 13:20:46 EDT 2025 Mon Sep 08 14:14:51 EDT 2025 Mon Jul 21 05:57:00 EDT 2025 Tue Jul 01 02:24:28 EDT 2025 Thu Apr 24 23:10:23 EDT 2025 Thu Apr 24 22:50:41 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
License | This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b468t-1c19e4f2f0f405ddbdc5920411ede9cc462f9e0b413665d5cd32894a0cf2bb1d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-5457-1402 |
OpenAccessLink | https://bmj.com/content/382/bmj-2023-075835.full |
PMID | 37532264 |
PQID | 2844894341 |
PQPubID | 2043523 |
ParticipantIDs | proquest_miscellaneous_2845656242 proquest_journals_2844894341 pubmed_primary_37532264 crossref_citationtrail_10_1136_bmj_2023_075835 crossref_primary_10_1136_bmj_2023_075835 bmj_journals_10_1136_bmj_2023_075835 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20230802 2023-08-02 |
PublicationDateYYYYMMDD | 2023-08-02 |
PublicationDate_xml | – month: 8 year: 2023 text: 20230802 day: 2 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMJ (Online) |
PublicationTitleAbbrev | BMJ |
PublicationTitleAlternate | BMJ |
PublicationYear | 2023 |
Publisher | British Medical Journal Publishing Group BMJ Publishing Group LTD |
Publisher_xml | – name: British Medical Journal Publishing Group – name: BMJ Publishing Group LTD |
References | (ref2) 2017; 130 Yao, Wang, Chang (ref16) 2021; 175 Ryu, Oh, Sohn, Lee (ref12) 2019; 116 Yao, Huang, Chang, Tsai, Wu, Tsai (ref15) 2020; 173 Gilstrap, Christensen, Clewell (ref1) 1995; 273 Mamdani, Sykora, Li (ref22) 2005; 330 Ninan, Liyanage, Murphy, Asztalos, McDonald (ref25) 2022; 176 Lunceford, Davidian (ref21) 2004; 23 Chien, Wu, Chang, Cheong, Yao, Tsai (ref18) 2022; 15 Matthews (ref29) 2000; 47 Orsida, Krozowski, Walters (ref30) 2002; 165 Räikkönen, Gissler, Tapiainen, Kajantie (ref9) 2022; 5 Vidaeff, Belfort, Kemp (ref6) 2023; 228 Haagsman, Diemel (ref28) 2001; 129 Stock, Thomson, Papworth (ref4) 2022; 129 Baisden, Sonne, Joshi, Ganapathy, Shekhawat (ref8) 2007; 28 Waljee, Rogers, Lin (ref14) 2017; 357 Wu, Lai, Gau, Wang, Tsai (ref19) 2014; 9 Sweet, Carnielli, Greisen (ref5) 2019; 115 McGoldrick, Stewart, Parker, Dalziel (ref24) 2020; 12 Liang, Tsai, Kuo, Tsai (ref13) 2021; 128 Alenius, Kajantie, Sund (ref23) 2023; 253 Benediktsson, Calder, Edwards, Seckl (ref7) 1997; 46 Dommasch, Kim, Lee, Gagne (ref17) 2019; 155 Glynn, Schneeweiss, Stürmer (ref20) 2006; 98 Pole, Mustard, To, Beyene, Allen (ref26) 2008; 70 Merrill, Ballard (ref27) 1998; 25 Räikkönen, Gissler, Kajantie (ref10) 2020; 323 Beksac, Korkmaz, Kasapoglu, Ozdemir, Cosgun, Tanacan (ref11) 2022; 35 2023080221000915000_382.aug02_8.e075835.26 2023080221000915000_382.aug02_8.e075835.27 2023080221000915000_382.aug02_8.e075835.24 2023080221000915000_382.aug02_8.e075835.25 2023080221000915000_382.aug02_8.e075835.22 2023080221000915000_382.aug02_8.e075835.23 2023080221000915000_382.aug02_8.e075835.20 2023080221000915000_382.aug02_8.e075835.21 2023080221000915000_382.aug02_8.e075835.28 2023080221000915000_382.aug02_8.e075835.29 2023080221000915000_382.aug02_8.e075835.30 2023080221000915000_382.aug02_8.e075835.15 2023080221000915000_382.aug02_8.e075835.1 2023080221000915000_382.aug02_8.e075835.16 2023080221000915000_382.aug02_8.e075835.13 2023080221000915000_382.aug02_8.e075835.14 2023080221000915000_382.aug02_8.e075835.11 2023080221000915000_382.aug02_8.e075835.12 2023080221000915000_382.aug02_8.e075835.10 2023080221000915000_382.aug02_8.e075835.19 2023080221000915000_382.aug02_8.e075835.17 2023080221000915000_382.aug02_8.e075835.18 2023080221000915000_382.aug02_8.e075835.8 2023080221000915000_382.aug02_8.e075835.9 2023080221000915000_382.aug02_8.e075835.6 2023080221000915000_382.aug02_8.e075835.7 2023080221000915000_382.aug02_8.e075835.4 2023080221000915000_382.aug02_8.e075835.5 2023080221000915000_382.aug02_8.e075835.2 2023080221000915000_382.aug02_8.e075835.3 37532272 - BMJ. 2023 Aug 2;382:1722 |
References_xml | – volume: 130 start-page: e102 year: 2017 ident: ref2 article-title: Committee Opinion No. 713: Antenatal Corticosteroid Therapy for Fetal Maturation publication-title: Obstet Gynecol – volume: 116 start-page: 369 year: 2019 ident: ref12 article-title: The Associations between Antenatal Corticosteroids and In-Hospital Outcomes of Preterm Singleton Appropriate for Gestational Age Neonates according to the Presence of Maternal Histologic Chorioamnionitis publication-title: Neonatology – volume: 70 start-page: 981 year: 2008 ident: ref26 article-title: Antenatal steroid therapy and childhood asthma: Is there a possible link? publication-title: Med Hypotheses – volume: 175 start-page: 723 year: 2021 ident: ref16 article-title: Association of Oral Corticosteroid Bursts With Severe Adverse Events in Children publication-title: JAMA Pediatr – volume: 15 start-page: 2409 year: 2022 ident: ref18 article-title: Associations between parental psychiatric disorders and autism spectrum disorder in the offspring publication-title: Autism Res – volume: 176 year: 2022 ident: ref25 article-title: Evaluation of Long-term Outcomes Associated With Preterm Exposure to Antenatal Corticosteroids: A Systematic Review and Meta-analysis publication-title: JAMA Pediatr – volume: 47 start-page: 291 year: 2000 ident: ref29 article-title: Antenatal glucocorticoids and programming of the developing CNS publication-title: Pediatr Res – volume: 323 start-page: 1924 year: 2020 ident: ref10 article-title: Associations Between Maternal Antenatal Corticosteroid Treatment and Mental and Behavioral Disorders in Children publication-title: JAMA – volume: 115 start-page: 432 year: 2019 ident: ref5 article-title: European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update publication-title: Neonatology – volume: 253 start-page: 135 year: 2023 ident: ref23 article-title: Risk-Taking Behavior of Adolescents and Young Adults Born Preterm publication-title: J Pediatr – volume: 129 start-page: e35 year: 2022 ident: ref4 article-title: Antenatal corticosteroids to reduce neonatal morbidity and mortality: Green-top Guideline No. 74 publication-title: BJOG – volume: 273 start-page: 413 year: 1995 ident: ref1 article-title: Effect of corticosteroids for fetal maturation on perinatal outcomes publication-title: JAMA – volume: 12 year: 2020 ident: ref24 article-title: Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth publication-title: Cochrane Database Syst Rev – volume: 330 start-page: 960 year: 2005 ident: ref22 article-title: Reader’s guide to critical appraisal of cohort studies: 2. Assessing potential for confounding publication-title: BMJ – volume: 25 start-page: 983 year: 1998 ident: ref27 article-title: Antenatal hormone therapy for fetal lung maturation publication-title: Clin Perinatol – volume: 228 start-page: 129 year: 2023 ident: ref6 article-title: Updating the balance between benefits and harms of antenatal corticosteroids publication-title: Am J Obstet Gynecol – volume: 128 start-page: 1497 year: 2021 ident: ref13 article-title: Antenatal corticosteroid therapy in late preterm delivery: a nationwide population-based retrospective study in Taiwan publication-title: BJOG – volume: 9 year: 2014 ident: ref19 article-title: Concordance between patient self-reports and claims data on clinical diagnoses, medication use, and health system utilization in Taiwan publication-title: PLoS One – volume: 46 start-page: 161 year: 1997 ident: ref7 article-title: Placental 11 beta-hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure publication-title: Clin Endocrinol (Oxf) – volume: 28 start-page: 1082 year: 2007 ident: ref8 article-title: Antenatal dexamethasone treatment leads to changes in gene expression in a murine late placenta publication-title: Placenta – volume: 173 start-page: 325 year: 2020 ident: ref15 article-title: Association Between Oral Corticosteroid Bursts and Severe Adverse Events: A Nationwide Population-Based Cohort Study publication-title: Ann Intern Med – volume: 165 start-page: 1010 year: 2002 ident: ref30 article-title: Clinical relevance of airway 11beta-hydroxysteroid dehydrogenase type II enzyme in asthma publication-title: Am J Respir Crit Care Med – volume: 98 start-page: 253 year: 2006 ident: ref20 article-title: Indications for propensity scores and review of their use in pharmacoepidemiology publication-title: Basic Clin Pharmacol Toxicol – volume: 5 year: 2022 ident: ref9 article-title: Associations Between Maternal Antenatal Corticosteroid Treatment and Psychological Developmental and Neurosensory Disorders in Children publication-title: JAMA Netw Open – volume: 35 start-page: 705 year: 2022 ident: ref11 article-title: Antenatal corticosteroids for women at risk of preterm delivery: the “Emperor’s New Clothes” tale in medical practice publication-title: J Matern Fetal Neonatal Med – volume: 23 start-page: 2937 year: 2004 ident: ref21 article-title: Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study publication-title: Stat Med – volume: 357 start-page: j1415 year: 2017 ident: ref14 article-title: Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study publication-title: BMJ – volume: 155 start-page: 1142 year: 2019 ident: ref17 article-title: Risk of Serious Infection in Patients Receiving Systemic Medications for the Treatment of Psoriasis publication-title: JAMA Dermatol – volume: 129 start-page: 91 year: 2001 ident: ref28 article-title: Surfactant-associated proteins: functions and structural variation publication-title: Comp Biochem Physiol A Mol Integr Physiol – ident: 2023080221000915000_382.aug02_8.e075835.25 doi: 10.1001/jamapediatrics.2022.0483 – ident: 2023080221000915000_382.aug02_8.e075835.22 doi: 10.1136/bmj.330.7497.960 – ident: 2023080221000915000_382.aug02_8.e075835.8 doi: 10.1016/j.placenta.2007.04.002 – ident: 2023080221000915000_382.aug02_8.e075835.1 doi: 10.1001/jama.1995.03520290065031 – ident: 2023080221000915000_382.aug02_8.e075835.29 doi: 10.1203/00006450-200003000-00003 – ident: 2023080221000915000_382.aug02_8.e075835.26 doi: 10.1016/j.mehy.2007.07.049 – ident: 2023080221000915000_382.aug02_8.e075835.19 doi: 10.1371/journal.pone.0112257 – ident: 2023080221000915000_382.aug02_8.e075835.24 doi: 10.1002/14651858.CD004454.pub4 – ident: 2023080221000915000_382.aug02_8.e075835.28 doi: 10.1016/S1095-6433(01)00308-7 – ident: 2023080221000915000_382.aug02_8.e075835.17 doi: 10.1001/jamadermatol.2019.1121 – ident: 2023080221000915000_382.aug02_8.e075835.7 doi: 10.1046/j.1365-2265.1997.1230939.x – ident: 2023080221000915000_382.aug02_8.e075835.10 doi: 10.1001/jama.2020.3937 – ident: 2023080221000915000_382.aug02_8.e075835.18 doi: 10.1002/aur.2835 – ident: 2023080221000915000_382.aug02_8.e075835.20 doi: 10.1111/j.1742-7843.2006.pto_293.x – ident: 2023080221000915000_382.aug02_8.e075835.15 doi: 10.7326/M20-0432 – ident: 2023080221000915000_382.aug02_8.e075835.11 doi: 10.1080/14767058.2020.1731455 – ident: 2023080221000915000_382.aug02_8.e075835.3 – ident: 2023080221000915000_382.aug02_8.e075835.13 doi: 10.1111/1471-0528.16677 – ident: 2023080221000915000_382.aug02_8.e075835.6 doi: 10.1016/j.ajog.2022.10.002 – ident: 2023080221000915000_382.aug02_8.e075835.30 doi: 10.1164/ajrccm.165.7.2105003 – ident: 2023080221000915000_382.aug02_8.e075835.5 doi: 10.1159/000499361 – ident: 2023080221000915000_382.aug02_8.e075835.12 doi: 10.1159/000502650 – ident: 2023080221000915000_382.aug02_8.e075835.16 doi: 10.1001/jamapediatrics.2021.0433 – ident: 2023080221000915000_382.aug02_8.e075835.23 doi: 10.1016/j.jpeds.2022.09.032 – ident: 2023080221000915000_382.aug02_8.e075835.21 doi: 10.1002/sim.1903 – ident: 2023080221000915000_382.aug02_8.e075835.4 doi: 10.1111/1471-0528.17027 – ident: 2023080221000915000_382.aug02_8.e075835.14 doi: 10.1136/bmj.j1415 – ident: 2023080221000915000_382.aug02_8.e075835.27 doi: 10.1016/S0095-5108(18)30093-9 – ident: 2023080221000915000_382.aug02_8.e075835.2 doi: 10.1097/AOG.0000000000002237 – ident: 2023080221000915000_382.aug02_8.e075835.9 doi: 10.1001/jamanetworkopen.2022.28518 – reference: 37532272 - BMJ. 2023 Aug 2;382:1722 |
SSID | ssj0002378965 |
Score | 2.5462604 |
Snippet | AbstractObjectiveTo investigate the associations between exposure to antenatal corticosteroids and serious infection in children during the first three, six,... To investigate the associations between exposure to antenatal corticosteroids and serious infection in children during the first three, six, and 12 months of... ObjectiveTo investigate the associations between exposure to antenatal corticosteroids and serious infection in children during the first three, six, and 12... |
SourceID | proquest pubmed crossref bmj |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | e075835 |
SubjectTerms | Adrenal Cortex Hormones - adverse effects Asthma Birth weight Cellulitis Child Child & adolescent mental health Children Children & youth Childrens health Chronic obstructive pulmonary disease Cohort analysis Cohort Studies Congenital diseases Corticosteroids Drug abuse Drug dosages Encephalitis Endocarditis Female Gastroenteritis Hospitals Humans Hypertension Immunology Immunomodulators Infections Maternal & child health Meningitis Mental disorders Multiple births Newborn babies Offspring Osteomyelitis Pneumonia Pregnancy Premature Birth Pyelonephritis Rheumatoid arthritis Sepsis Siblings Socioeconomic factors Steroids Taiwan - epidemiology |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3LS8MwGA86QbyIb6dTInjwEtemaZp6ERFFBD052K00L1C0m9vEf9_va9NND_NW8mjLL1_yPfI9CDl3iTLG25LxTKVMWOdYqXLOyizNSp3HykYYjfz0LB8G4nGYDoPBbRrcKtszsT6o7cigjbwPx6jAXOEivh5_MqwahberoYTGKlmrU5cBPWfDbG5j4UmmcpmGjD5xIvv6441hwXAGnFJhibdVaPnLkpbImTW_ud8im0FQpDfNym6TFVftkPWncBW-S8a_gKXB24oiTBUaZCgolTARIzgmo1c7hR5L0Y2cjjxFqgOFn7aOWBU80Taq-4o29sHvV-sols-dzGidg3aPDO7vXm4fWCifwLSQasZiE-dOeO4jD1KZtdqaNOeRiGNnXW6MkNznLtLAxqRMbWpsAtqXKCPjudaxTfZJpxpV7pBQJ3WUArdPPMhPwOuU9xw2svNSmDxSrkvOAccikP-0qDWLRBbYiHAXDdxdctkCXZiQghwrYbwvn3AxnzBusm8sH9prV27xHwui6ZKzeTdsILwVKSsHWOMYFGpBVOmSg2bF599KQJnDSOOj_19-TDYaolIs4j3SmU2-3AnIKjN9WhPkDxQ26FE priority: 102 providerName: ProQuest |
Title | Association between antenatal corticosteroids and risk of serious infection in children: nationwide cohort study |
URI | https://bmj.com/content/382/bmj-2023-075835.full https://www.ncbi.nlm.nih.gov/pubmed/37532264 https://www.proquest.com/docview/2844894341 https://www.proquest.com/docview/2845656242 |
Volume | 382 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1La9wwEB7ygJBLadLXtumiQg69KJUlWZZ7S0NCCGwoJSnbk7FekNB6w8Yhf78zfmwfsJCTjSVh-9OI-WakmQE4jMp6n0LNZWFzrkOMvLal5HWRF7UrMxsERSPPLs35tb6Y5_MNEGMsjPt120cyUG6mpv2krKRnnKp8c1RvSBiOyDG9CdtUmqSrWfDjauVVkaqwpcmHHD6ZMv8P3oUdhQydwkdRm2Djv_poDcnslM3Zc3g2sER23E_rHmzEZh92ZsM--Au4-wtVNhy1YoRRQ94YhhYlDqTwjeXiJtxjS2B0hpwtEiORQ2ufjaewGrxjY0j3Z9Y7Bx9vQmRUO3fZsi4B7Uu4Pju9OjnnQ-0E7rSxLc98VkadZBIJKVkILvi8lEJnWQyx9F4bmcooHOowY_KQ-6DQ9NK18Ek6lwX1CraaRRPfAIvGiRxVvUoIGio6m5LEVRyT0b4UNk7gEHGsBtm_rzqzQpmKHhLyVY_8BI5GoCs_5B-nMhg_1w_4uBpw16feWN_1YJy5P9-BildTdnmdTeDDqhlXD22J1E1ErKkPMVrkKRN43c_46l2jnLx92v-9g91eziwX8gC22uVDfI-EpXVT2CzmxbST1ClsH5_MZt_x-uX08uu33xi76K4 |
linkProvider | BMJ Publishing Group Ltd |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1dT9RAcAJHorwYEJVTxDXBxJeVdrvd25IYIwg5Pu5iDCS81e5XgtH2vDtC_FP8Rmau7aEP5xtvzXZ328zMztfOB8COT7S1wRVc9HTKpfOeFzoTvOilvcJksXYRZSMPhqp_IU8u08sluG1zYSissuWJM0btKks-8l1ko5Jqhcv40-g3p65RdLvattCoyeLU_7lBk23y8fgL4vedEEeH5wd93nQV4EYqPeWxjTMvgwhRQGXFOeNsmolIxrF3PrNWKhEyHxnk7kqlLrUuQaNEFpENwpjYJbjvMqxIymjtwMr-4fDrt7lXRyQ9nam0qSGEO-yaXz84tSjnKJs1NZVbxpF_heACzXYm4Y7W4EmjmrLPNS2tw5Ivn8KjQXP5vgGjv1DJmvguRogpyQXE0IzFhZQzMq6u3ATfOEaB66wKjOi8up6wNvSrxCfW5pHvsdojeXPlPKOGveMpm1W9fQYXDwLa59Apq9JvAvPKRCnqF0lAjQ2lqw5BIOvwQUmbRdp3YQfhmDcHbpLPbJlE5TRI4M5rcHfhQwvo3DZFz6n3xs_FC97PF4zqeh-Lp261mLv_j3sy7cLb-Ws8snQPU5QeYU1zSI1G5agLL2qMz7-VoPlIuc0v_7_5G3jcPx-c5WfHw9NXsFoTmOaR2ILOdHztX6OmNDXbDXky-P7QJ-IOjsMneQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bT9RAFD7hkhBfjOCFRZQxwcSXcdvpdDo1McSAGxAhPkiyb7VzSzDaLrtLiH_NX-c5vSzysLzx1rQzbXNu852ZcwHY94m2NriSi0ynXDrvealzwcsszUqTx9pFlI18dq6OL-SXcTpegb99LgyFVfY2sTHUrra0Rz5EMyqpVriMh6ELi_h2NDqYXHHqIEUnrX07jVZETv2fG3TfZh9PjpDXb4UYff5-eMy7DgPcSKXnPLZx7mUQIQoIXJwzzqa5iGQce-dza6USIfeRQUuvVOpS6xJ0UGQZ2SCMiV2C712F9SxBVIW6lI2zxf6OSDKdq7SrJoTzh-b3T07Nyjmu0pray63inbvL4RKM26x1oyfwuAOp7FMrVZuw4qst2DjrjuGfwuQ_prIu0osRiyraDGLo0OJEyh6Z1pduhk8coxB2VgdGEl9fz1gfBFbhFeszyj-wdm_y5tJ5Rq17p3PW1L99BhcPQtjnsFbVld8G5pWJUkQaSUDshuusDkGgEfFBSZtH2g9gH-lYdKo3KxqvJlEF3SRyFy25B_C-J3Rhu_Ln1IXj1_IJ7xYTJm3lj-VDd3vO3f7HrcAO4M3iMSovnciUlUda0xgC1AiTBvCi5fjiWwk6kpTlvHP_y_dgA_Wg-HpyfvoSHrXypXkkdmFtPr32rxAyzc3rRjYZ_HhoZfgH9TEqQA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+antenatal+corticosteroids+and+risk+of+serious+infection+in+children%3A+nationwide+cohort+study&rft.jtitle=BMJ.+British+medical+journal+%28Clinical+research+ed.%29&rft.au=Yao%2C+Tsung-Chieh&rft.au=Chang%2C+Sheng-Mao&rft.au=Wu%2C+Chi-Shin&rft.au=Tsai%2C+Yi-Fen&rft.date=2023-08-02&rft.eissn=1756-1833&rft.volume=382&rft.spage=e075835&rft_id=info:doi/10.1136%2Fbmj-2023-075835&rft_id=info%3Apmid%2F37532264&rft.externalDocID=37532264 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1756-1833&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1756-1833&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1756-1833&client=summon |